Abstract
The mammalian target of rapamycin (mTOR) protein complexes are involved in neuropathic pain by regulating neuroinflammation. Modulation of mTOR pathways, and associated phosphorylation, might disrupt neuropathic pain. Spinal cord stimulation (SCS) with differential target multiplexed programming provided better analgesia than low rate SCS (LR) in an animal model of neuropathic pain. Differential Target Multiplexed SCS acts by modulating biological processes that were perturbed by neuropathic pain.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Paper Title
Journal
Date
